Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Category : Search result: pharma company valuation
Smallcap Pharma Stock Gains 10% Despite Market Sell-Off
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
IPO Market Sees ₹76,000 Crore Pipeline in Nov 2025
India's IPO market surges with ₹76,000 crore offerings. Excelsoft Technologies fully subscribed, Sudeep Pharma at 50%. Expert analysis on both IPOs and GMP trends revealed.
Sudeep Pharma IPO: ₹895 Cr Offer Opens, ₹130 Grey Market Premium
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma IPO: ₹895 Crore Offer Opens Today
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
Havells Q2: 5% Revenue Growth vs 63x P/E Valuation
Havells reports weak 5% revenue growth with Lloyd AC business crashing 18%. Despite cable segment strength, stock trades at premium 63x earnings. Is the valuation justified?
Jagannath Temple Jewelry Won't Get Price Tag in Inventory
The Shree Jagannath Temple Administration plans inventory without jewelry valuation due to medieval ornaments' complexity. Religious sanctity prioritized over monetary assessment.
IBBI's New Valuation Format Aims to Cut Litigation
IBBI introduces standardized valuation format for distressed assets to enhance transparency and reduce lawsuits. Public feedback accepted until December 10. Learn how this impacts creditors.
Indian IPO Market 2025: 33% List Below Issue Price
India's IPO market remains active in 2025 but faces value concerns. 32 of 92 mainboard IPOs listed below issue price. Experts advise selective, valuation-conscious investing for sustainable returns.
Sudeep Pharma IPO: 22% GMP, Opens Nov 21
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Multan Sultans Owner Accuses PCB of Ghosting
Multan Sultans owner Ali Khan Tareen claims PCB has excluded franchise from PSL valuation process. Read about the escalating conflict and potential legal action.
Sudeep Pharma IPO: ₹895 Cr Issue Opens Nov 21
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Microsoft, Nvidia invest $15B in AI startup Anthropic
Microsoft and Nvidia invest $15 billion in AI startup Anthropic, skyrocketing its valuation to $350 billion. Discover how this reshapes the AI industry and challenges OpenAI.
Sensex rally stands on shaky ground, shows analysis
Sensex's recent peak masks a narrow rally where over two-thirds of BSE stocks fell. Experts call it a late-cycle reset. Read key market insights.
Sudeep Pharma IPO: Price Band ₹563-593 Per Share
Sudeep Pharma IPO opens November 21 with price band ₹563-593 per share. Company aims to raise ₹95 crore. Learn key dates, financials, and investment details.
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
Silicon Valley's $1 Trillion Unicorn Quest Reshapes VC
Silicon Valley VCs chase first $1 trillion unicorn as AI boom transforms investment strategies. Learn how Nvidia's $4 trillion success fuels this high-stakes race.
Perplexity Leads AI Bubble Concerns in Valley Survey
Silicon Valley conference attendees name Perplexity and OpenAI as most vulnerable AI startups amid growing bubble fears. Read about investor concerns and billion-dollar valuations.
Earnings Revival Key to Reverse India's Market Lag
Edelweiss MF's Trideep Bhattacharya explains how corporate earnings recovery could reverse India's global underperformance and bring back FIIs within 12 months. Read expert market analysis.
Hvax Technologies H1 FY26 Income Jumps 35%
Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.
European Pharma Stocks Rebound from AI Shift
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.
Purdue Pharma Wins Bankruptcy Approval in Opioid Case
Purdue Pharma receives court approval for $7.4 billion opioid settlement after Supreme Court intervention. Sackler family to pay $6.5 billion over 15 years in landmark case.
Purdue Pharma $7B Opioid Settlement Gets Court Nod
Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Skims Hits $5B Valuation, Kim Kardashian's Wealth Soars
Kim Kardashian's shapewear brand Skims reaches $5 billion valuation after latest funding round, boosting her personal fortune to $1.9 billion. Discover how the brand is expanding globally.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Pine Labs IPO: 54% Subscribed, Closes Today
Pine Labs' ₹3,900 crore IPO was 54% subscribed by Day 2. The offer, with a price band of ₹210-221 per share, closes today. Discover the latest GMP and fund allocation details.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
Page 1 of 4